Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm ltd. - nateglinide - diabetes mellitus, tipo 2 - drogas usadas em diabetes - nateglinide está indicado para terapia combinada com metformina em pacientes diabéticos tipo 2 inadequadamente controlados, apesar de uma dose máxima de metformina tolerada.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asma - medicamentos para obstrutiva, doenças das vias respiratórias, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - asma - medicamentos para obstrutiva, doenças das vias respiratórias, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asma - medicamentos para obstrutiva, doenças das vias respiratórias, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoma, pulmão de células não pequenas - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Brasiilia - portugali - ANVISA (Agência Nacional de Vigilância Sanitária)

novartis biociencias s.a - budesonida - outros medicamentos antiasmaticos

Brasiilia - portugali - ANVISA (Agência Nacional de Vigilância Sanitária)

novartis biociencias s.a - antinflamatorios

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hipertensão - agentes que atuam no sistema renina-angiotensina - tratamento da hipertensão essencial. imprida é indicado em doentes cuja pressão arterial não é adequadamente controlada em amlodipina ou valsartan em monoterapia.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmológicos - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Euroopa Liit - portugali - EMA (European Medicines Agency)

novartis europharm limited - cloridrato de olopatadina - conjuntivite, alergica - oftalmológicos - tratamento de sinais e sintomas oculares de conjuntivite alergica sazonal.